The National Institute of Neurological Disorders and Stroke (NINDS), part of the Department of Health and Human Services, awarded a $4,528,840 Project Grant to The Salk Institute For Biological Studies under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The three-year award beginning August 19, 2022 will fund research to functionally dissect cerebellar output circuits that orchestrate limb motor control. Specifically, the grantee will...
This $1,127,000 federal Project Grant award from the National Institutes of Health (NIH) Office of the Director's Trans-NIH Research Support program (CFDA 93.310) will fund a transformative research program at Duke University to map and dissect the brainstem neural circuits that coordinate orofacial rhythmic movements such as licking, breathing, and swallowing. The research aims to shed light on the neural mechanisms underlying these critical life functions and how they may be impacted in...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, aims to develop a synthetic biological system to manipulate subcellular RNAs and proteins in growth cones or synapses of subtype- and context-specific neurons. The $481,250 award, spanning September 2024 to September 2026, will enable the researchers to integrate subcellular...
This federal Project Grant award of $270,434.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research by Princeton University to investigate the spatial and temporal regulation of the chickadee (chic) transcript during neuronal remodeling in Drosophila neurons. The research aims to elucidate the role of mRNA localization and translation in regulating...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $244,154 to Albert Einstein College of Medicine to investigate the regulation of presynaptic gene transcripts during synaptogenesis in the nematode C. elegans. The research aims to characterize the dynamics of the SYD-2/LIPRIN-alpha mRNA and identify novel candidates for mRNA...
This federal Project Grant award, valued at $161,072, was provided by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173). The award supports research to investigate the role of the FOXP2 transcription factor in the development of the auditory pathway and its potential impact on sensory processing deficits seen in neurodevelopmental disorders like autism spectrum disorder. The...
This $632,243 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to understand the molecular and cellular mechanisms of cerebellar dysfunction in neurodevelopmental disorders (NDDs). The primary goal is to elucidate how disruptions to cerebellar inhibitory neurons, particularly Purkinje cells and GABAergic interneurons,...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $127,145.00 to support research on the regulatory mechanisms governing chromatin organization and gene transcription during neural development in the Drosophila model organism. The key focus areas of the research include: 1) Identifying focal contact anchors that contribute...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $2,503,949.00 to Rockefeller University to develop new techniques and concepts aimed at discovering therapeutic targets for neurological diseases. The primary goals are to understand the fundamental mechanisms of brain disease, including how differences in cell...
This Project Grant award of $169,500 was provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) to Weill Medical College of Cornell University. The funding will support research to identify the direct binding targets of the transcription factor FOXP1 in human cortical neural progenitor cells and neurons. The goal is to elucidate the transcriptional networks regulated by FOXP1 in order to further the understanding of the disease...